4096.0: Tuesday, October 23, 2001: 12:30 PM-2:00 PM | ||||
Oral Session | ||||
| ||||
| See individual abstracts for presenting author's disclosure statement. | ||||
| Learning Objectives: Learning Objectives for the Healthy Aging Project’s Medicare Stop Smoking Program At the completion of the symposium, the participant in this session will be able to: 1. Recognize the impact of tobacco-related illnesses on the Medicare program’s health care spending. 2. Describe the evidence supporting various smoking cessation interventions targeting older smokers. 3. Identify the smoking cessation interventions that the Health Care Financing Administration (HCFA) will test as potential new Medicare benefits in a national trial. 4. Describe the effectiveness and costs of alternative smoking cessation interventions that will be tested as potential new Medicare benefits. | ||||
| James Coan | ||||
| Margaret Maglione, MPP | ||||
| SESSION ABSTRACT - Smoking cessation: A Medicare priority Margaret Maglione, MPP, Erin G. Stone, MD | ||||
| A review of effectiveness of smoking cessation interventions: Implications for Medicare Paul G. Shekelle, MD, PhD, Sally A. Morton, PhD, Margaret Maglione, MPP, Walter Mojica, MD, MPH, Erin Stone, MD | ||||
| Healthy Aging Project's Medicare Stop Smoking Program Jeanette A. Preston, MD, MPH, Judith K. Barr, ScD, Jennifer Mongoven, BA, Laurence Z. Rubenstein, MD, MPH, Richard W. Besdine, MD, FACP | ||||
| A cost-benefit analysis of the Medicare Stop Smoking Program Geoffrey F. Joyce, PhD, Shin-Yi Wu, PhD, Jeanette A. Preston, MD, MPH, Laurence Z. Rubenstein, MD, MPH, Paul G. Shekelle, MD, PhD | ||||
| Discussion: James Coan, MD, Health Care Financing Administration | ||||
| Sponsor: | Alcohol, Tobacco, and Other Drugs | |||
| Cosponsors: | Community Health Planning and Policy Development; Social Work | |||
| CE Credits: | CME, Health Education (CHES), Nursing, Pharmacy, Social Work | |||